Capricor Therapeutics【CAPR】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

12.88

買値

12.83

売値

12.89

出来高

336,684

12.67 日の範囲 13.4235

3.52 52 週間の範囲 23.40

時価総額

585.652M

前日終値

13.07

始値

13.08

時刻

100

12.88

最終取引時間

01:52:35

財務取引量

US$ 4,365,431

VWAP

12.966

平均取引量 (3 か月)

1,165,597

発行済株式数

45,469,908

配当利回り

PER

-26.52

1 株当たり利益 (EPS)

-0.49

歳入

25.18M

純利益

-22.29M

Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell t... Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is currently in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). Capricor is also developing its exosome technology as a next-generation therapeutic platform. Capricor's proprietary StealthX¿ exosome platform has potential for a broad range of new therapeutic applications in the field of vaccinology as well as targeted oligonucleotide, protein and small molecule therapeutics to treat or prevent a variety of diseases. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.capricor.com

本社

Wilmington, Delaware, USA

設立

Capricor Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker CAPR. The last closing price for Capricor Therapeutics was US$13.07. Over the last year, Capricor Therapeutics shares have traded in a share price range of US$ 3.52 to US$ 23.40.

Capricor Therapeutics currently has 45,469,908 shares in issue. The market capitalisation of Capricor Therapeutics is US$594.29 million. Capricor Therapeutics has a price to earnings ratio (PE ratio) of -26.52.

Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19

SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company...

Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy

--FDA assigns PDUFA target action date of August 31, 2025-- --If approved, deramiocel would be first therapy to...

Form 4 - Statement of changes in beneficial ownership of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.32	2.54777070064	12.56	14.005	11.7501	1371934	12.8809129	CS
4	-2.27	-14.9834983498	15.15	16.465	11.7501	1545925	14.14556186	CS
12	0.19	1.49724192277	12.69	16.465	11.7501	1165597	14.08325517	CS
26	8.65	204.491725768	4.23	23.4	4.2	2372804	14.48730204	CS
52	6.98	118.305084746	5.9	23.4	3.52	1348201	13.27601458	CS
156	8.7	208.133971292	4.18	23.4	2.68	556228	11.53006855	CS
260	11.59	898.449612403	1.29	23.4	0.9301	952783	8.08517368	CS

CAPR - Frequently Asked Questions (FAQ)

What is the current Capricor Therapeutics share price?

The current share price of Capricor Therapeutics is US$ 12.88

How many Capricor Therapeutics shares are in issue?

Capricor Therapeutics has 45,469,908 shares in issue

What is the market cap of Capricor Therapeutics?

The market capitalisation of Capricor Therapeutics is USD 594.29M

What is the 1 year trading range for Capricor Therapeutics share price?

Capricor Therapeutics has traded in the range of US$ 3.52 to US$ 23.40 during the past year

What is the PE ratio of Capricor Therapeutics?

The price to earnings ratio of Capricor Therapeutics is -26.52

What is the cash to sales ratio of Capricor Therapeutics?

The cash to sales ratio of Capricor Therapeutics is 23.48

What is the reporting currency for Capricor Therapeutics?

Capricor Therapeutics reports financial results in USD

What is the latest annual turnover for Capricor Therapeutics?

The latest annual turnover of Capricor Therapeutics is USD 25.18M

What is the latest annual profit for Capricor Therapeutics?

The latest annual profit of Capricor Therapeutics is USD -22.29M

What is the registered address of Capricor Therapeutics?

The registered address for Capricor Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Capricor Therapeutics website address?

The website address for Capricor Therapeutics is www.capricor.com

Which industry sector does Capricor Therapeutics operate in?

Capricor Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
RGCRegencell Bioscience Holdings Ltd	US$ 10.4004 (147.63%)	13.74M
HMRHeidmar Maritime Holdings Corporation	US$ 4.128 (61.88%)	61.65M
SPGCSacks Parente Golf Inc	US$ 0.15865 (46.90%)	331M
LFWDLifeward Ltd	US$ 2.0395 (38.74%)	95.87M
AVAHAveanna Healthcare Holdings Inc	US$ 5.0247 (34.35%)	2.23M
ADTXAditxt Inc	US$ 0.0364 (-35.92%)	92.71M
ULYUrgent ly Inc	US$ 0.3301 (-35.22%)	1.48M
QRHCQuest Resource Holding Corporation	US$ 2.67 (-30.65%)	401.7k
SPHLSpringview Holdings Ltd	US$ 0.873549 (-29.55%)	1.5M
KBSXFST Corporation	US$ 2.19 (-29.35%)	52.06k
SPGCSacks Parente Golf Inc	US$ 0.15865 (46.90%)	331M
INTCIntel Corporation	US$ 23.985 (15.98%)	166.97M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 8.325 (-8.92%)	165.21M
NVDANVIDIA Corporation	US$ 116.033 (0.25%)	164.01M
DMNDamon Inc	US$ 0.1841 (3.02%)	101.73M